Bayer Rises as BofAML Predicts New Drug Success: Frankfurt Mover

Published January 25, 2013

Bayer Rises as BofAML Predicts New Drug Success: Frankfurt Mover

Filed under: drug rehab treatment programs

Bayer made progress last year with blood thinner Xarelto, eye drug Eylea, lung treatment riociguat, colorectal cancer medicine Stivarga and prostate cancer drug Alpharadin. The company gave its peak annual sales forecast of 5.5 billion euros for the …
Read more on Bloomberg

Geron Corporation's Recent Catalysts

Filed under: drug rehab treatment programs

Last month on December 10th, the company reported early clinical trial results for its drug imetelstat as a treatment for a blood platelet disorder. Geron said 100 percent of patients responded to the drug, and most patients who had a specific gene …
Read more on Seeking Alpha

Researchers study innovative stem cell drug for treating localized cartilage …

Filed under: drug rehab treatment programs

Treating cartilage damage can be problematic because the tissue does not contain blood vessels or nerves and therefore has a limited ability to re-grow. Various treatments for cartilage degeneration, such as drug therapy, arthroscopy and joint …
Read more on News-Medical.net